Pharmacokinetics and Pharmacodynamics, Efficacy and Safety of Omalizumab in Japanese Children (6 - 15 Years)
Clinical trial NCT01155700 · COMPLETED
Trial details
- NCT number
- NCT01155700
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2012-02-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.